TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
OVID

Ovid Therapeutics Inc

Healthcare · Biotechnology

2.50$ -0.4% vs. previous close Closing price · As of: Nov 13, 2026

Investor relations

Report Dates

Investor relations overview for Ovid Therapeutics Inc (OVID): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/11/2026.

Next report 11/11/2026
Last report 11/10/2026
Earnings surprise by quarter (%)
Q4 23 · -340.0 % 23 Q1 24 · 26.1 % 24 Q2 24 · 150.0 % 24 Q3 24 · 13.0 % 24 Q4 24 · 22.2 % 24 Q1 25 · -7.7 % 25 Q2 25 · 60.0 % 25 Q3 25 · -13.3 % 25 Q4 25 · 152.8 % 25 Q1 26 · -9.1 % 26 Q2 26 · 20.0 % 26 Q3 26 · -25.0 % 26

EPS estimate beaten

Full history 23 of 39 quarters (59%)
Last 16 quarters 10 of 16 quarters (63%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 11/10/2026 Ovid Therapeutics Inc. (OVID): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/13/2026 Ovid Therapeutics Inc. (OVID): Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?